Catalyst Wire Dossier Catalyst Wire Dossier

Autologous bone marrow-derived mesenchymal stem cells in fibrin

bone marrow-derived mesenchymal stem cells in fibrin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous bone marrow-derived mesenchymal stem cells in fibrin, covering 2016-10-04 to 2016-10-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Effectiveness of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Fibrin to Treat Chronic Wounds [Phase 1]

See pricing